Contact Us

This is a promotional website intended for healthcare professionals in the UK and Ireland only.

For enquiries about ordering BRUKINSA (zanubrutinib) in England, Scotland or Wales, please contact ukorders@beigene.com.

For enquiries about ordering BRUKINSA (zanubrutinib) in Northern Ireland or Ireland, please contact IE.orders@beigene.com. 

If you would like to speak to our pharmacy liaison manager, please contact Nisa Khan nisa.khan@beigene.com. 

For medical information, please contact: UK: 08004320266, Ireland: 1800946589 or email: medicalinformationEU@beigene.com

If you have any general questions, please contact ukandirelandgeneralinquiries@beigene.com.

Adverse events should be reported

United Kingdom (incl. Northern Ireland): Healthcare Professionals are asked to report any suspected adverse reactions via Yellow Card Scheme found at https://yellowcard.mhra.gov.uk/.
Ireland: Healthcare Professionals are asked to report any suspected adverse reactions via HPRA at www.HPRA.ie.

All adverse events (UK and Ireland) should also be reported to BeiGene at adverse_events@beigene.com; (UK: 08009176799; Ireland: 1800812061).

For medical information, please contact: UK: 08004320266, Ireland: 1800946589 or email: medicalinformationEU@beigene.com

▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

November 2023 [1023-BRU-PRC-088]

Back to top

Brukinsa®▼ UK and Ireland healthcare professional website

This website contains information on BRUKINSA (zanubrutinib) and is intended for healthcare professionals in the UK and Ireland only.

To direct you to the most appropriate information, please confirm you are a UK or Ireland Healthcare Professional.

If you are not a UK or Ireland Healthcare Professional, you will be directed to the BRUKINSA Patient Information leaflet.

Are you a UK or Ireland Healthcare Professional?

0823-BRU-PRC-184 | September 2023

No, I am not

You are about to leave the BRUKINSA®▼ site